IP Library Granted Patent US 10,369,237
Granted Patent B2
US 10,369,237 · App. 15/122,749 · Granted Aug 6, 2019

Sterilization and filtration of peptide compositions

Inventors: Eun Seok Gil (Acton, MA); Karl Patrick Gilbert (Danvers, MA)
Assignee: 3-D Matrix, LTD.
A61L2/022A61L2/04A61L2/07C07K7/08A61L2202/21
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,369,237
App. No.
15/122,749
Granted
Aug 6, 2019
Kind
B2
Abstract

Methods and devices for sterilizing viscous peptide compositions which have shear thinning rheological properties at high concentrations.

Claims (9)

1. A method for sterilizing a liquid peptide composition whose sequence comprises a series of repeating units of IEIK as set forth in SEQ ID NO:6 comprising subjecting the liquid peptide composition to autoclave treatment.

2. The method of claim 1 , wherein the method does not involve sterilizing filtration.

3. A method for sterilizing a liquid peptide composition whose sequence comprises a series of repeating units of IEIK as set forth in SEQ ID NO:6 comprising subjecting the liquid peptide composition to heat treatment performed at about 121° C. for about 25 minutes.

4. The method of claim 1 , wherein the liquid peptide composition has a concentration within the range of about 0.01% to about 10%.

5. The method of claim 1 , wherein the liquid peptide composition comprises IEIK13 as set forth in SEQ ID NO: 3.

6. The method of claim 1 , wherein the method does not degrade the liquid peptide composition.

7. The method of claim 3 , wherein the liquid peptide composition has a concentration within the range of about 0.01% to about 10%.

8. The method of claim 3 , wherein the liquid peptide composition comprises IEIK13 as set forth in SEQ ID NO: 3.

9. The method of claim 3 , wherein the method does not degrade the liquid peptide composition.

Continuity (2)
Provisional Application 61950536 · Mar 10, 2014
Related Publication 20170202986A1 · Jul 20, 2017